Based on numerous reported examples of GSK3β inhibitors (Compounds V, VI, and VIII) and docking studies, we predicted that hybridizing pyridyl ring with oxindole or its N bioisostere would provide us with dual-acting anti-AD chemotypes, particularly as anti-tau and GSK3β inhibitors (Figure 2). This evidence concerns the gene MAPT and Alzheimer disease.